These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15534065)

  • 1. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
    Spaeth N; Wyss MT; Weber B; Scheidegger S; Lutz A; Verwey J; Radovanovic I; Pahnke J; Wild D; Westera G; Weishaupt D; Hermann DM; Kaser-Hotz B; Aguzzi A; Buck A
    J Nucl Med; 2004 Nov; 45(11):1931-8. PubMed ID: 15534065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
    Spaeth N; Wyss MT; Pahnke J; Biollaz G; Lutz A; Goepfert K; Westera G; Treyer V; Weber B; Buck A
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):673-82. PubMed ID: 16538503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
    Wyss MT; Spaeth N; Biollaz G; Pahnke J; Alessi P; Trachsel E; Treyer V; Weber B; Neri D; Buck A
    J Nucl Med; 2007 Apr; 48(4):608-14. PubMed ID: 17401099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
    Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
    Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
    Sai KK; Huang C; Yuan L; Zhou D; Piwnica-Worms D; Garbow JR; Engelbach JA; Mach RH; Rich KM; McConathy J
    J Nucl Med; 2013 Jul; 54(7):1120-6. PubMed ID: 23650628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
    DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE
    J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
    Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P
    Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
    J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
    Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of 18F-FCH Uptake in Human T98G Glioblastoma Cells.
    Buroni FE; Pasi F; Persico MG; Lodola L; Aprile C; Nano R
    Anticancer Res; 2015 Dec; 35(12):6439-43. PubMed ID: 26637854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
    Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-Related Uptake of
    Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
    J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.
    Salber D; Stoffels G; Pauleit D; Oros-Peusquens AM; Shah NJ; Klauth P; Hamacher K; Coenen HH; Langen KJ
    J Nucl Med; 2007 Dec; 48(12):2056-62. PubMed ID: 18006612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
    Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
    J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    Bolcaen J; Lybaert K; Moerman L; Descamps B; Deblaere K; Boterberg T; Kalala JP; Van den Broecke C; De Vos F; Vanhove C; Goethals I
    PLoS One; 2016; 11(8):e0161845. PubMed ID: 27559736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.
    Stegmayr C; Willuweit A; Lohmann P; Langen KJ
    Curr Radiopharm; 2019; 12(3):201-210. PubMed ID: 30636621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia.
    Salber D; Stoffels G; Pauleit D; Reifenberger G; Sabel M; Shah NJ; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2006 Nov; 33(8):1029-35. PubMed ID: 17127177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.